HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LQFM-091

a dual 5-lipoxygenase (5-LOX) and cyclo-oxygenase inhibitor and

Also Known As:

2,6-di-tert-butyl-4-((4-nitrophenylamino)methyl)phenol

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Benzene Derivatives: 17
        Phenols: 677
        LQFM-091: 1

Experts

1.	Batista, Daniel da Costa: 1 article (08/2017)
2.	Costa, Elson Alves: 1 article (08/2017)
3.	Florentino, Iziara Ferreira: 1 article (08/2017)
4.	Gil, Eric de Souza: 1 article (08/2017)
5.	Leite, Karla Carneiro de Siqueira: 1 article (08/2017)
6.	Lino, Roberta Campos: 1 article (08/2017)
7.	Lião, Luciano M: 1 article (08/2017)
8.	Martins, José Luís Rodrigues: 1 article (08/2017)
9.	Menegatti, Ricardo: 1 article (08/2017)
10.	Silva, Andreia Luiza Pereira: 1 article (08/2017)

Related Diseases

1.	Hyperalgesia 08/30/2017 - "A formalin test, a hot plate test and carrageenan-induced mechanical hyperalgesia were employed to evaluate the analgesic nature of LQFM-091. "
2.	Edema (Dropsy) 08/30/2017 - "Furthermore, LQFM-091 reduced the paw edema induced by carrageenan and reduced the leukocyte count, myeloperoxidase activity, TNF-α and IL-1β levels in the pleural exudate. "

Related Drugs and Biologics

1.	Peroxidase (Myeloperoxidase)
2.	Formaldehyde (Formol)
3.	Carrageenan
4.	Analgesics (Analgesic Drugs)